<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H662E246595504A6184FD2F10D0770EFD" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 4076 IH: United States-Israel Health Technologies Cooperation Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-06-13</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 4076</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230613">June 13, 2023</action-date><action-desc><sponsor name-id="P000614">Mr. Pappas</sponsor> (for himself, <cosponsor name-id="P000613">Mr. Panetta</cosponsor>, <cosponsor name-id="S000168">Ms. Salazar</cosponsor>, <cosponsor name-id="C001120">Mr. Crenshaw</cosponsor>, <cosponsor name-id="G000577">Mr. Graves of Louisiana</cosponsor>, <cosponsor name-id="M000194">Ms. Mace</cosponsor>, <cosponsor name-id="V000133">Mr. Van Drew</cosponsor>, <cosponsor name-id="W000823">Mr. Waltz</cosponsor>, <cosponsor name-id="N000193">Mr. Nunn of Iowa</cosponsor>, <cosponsor name-id="F000466">Mr. Fitzpatrick</cosponsor>, <cosponsor name-id="G000593">Mr. Gimenez</cosponsor>, <cosponsor name-id="E000235">Mr. Ezell</cosponsor>, <cosponsor name-id="D000628">Mr. Dunn of Florida</cosponsor>, <cosponsor name-id="M001194">Mr. Moolenaar</cosponsor>, <cosponsor name-id="L000599">Mr. Lawler</cosponsor>, <cosponsor name-id="L000564">Mr. Lamborn</cosponsor>, <cosponsor name-id="M001195">Mr. Mooney</cosponsor>, <cosponsor name-id="M001221">Mr. Molinaro</cosponsor>, <cosponsor name-id="K000394">Mr. Kim of New Jersey</cosponsor>, <cosponsor name-id="D000230">Mr. Davis of North Carolina</cosponsor>, <cosponsor name-id="C001133">Mr. Ciscomani</cosponsor>, <cosponsor name-id="A000375">Mr. Arrington</cosponsor>, <cosponsor name-id="M001136">Mrs. McClain</cosponsor>, <cosponsor name-id="B001298">Mr. Bacon</cosponsor>, <cosponsor name-id="G000583">Mr. Gottheimer</cosponsor>, <cosponsor name-id="M001217">Mr. Moskowitz</cosponsor>, <cosponsor name-id="A000148">Mr. Auchincloss</cosponsor>, <cosponsor name-id="L000582">Mr. Lieu</cosponsor>, <cosponsor name-id="S001150">Mr. Schiff</cosponsor>, <cosponsor name-id="T000487">Ms. Tokuda</cosponsor>, <cosponsor name-id="K000381">Mr. Kilmer</cosponsor>, <cosponsor name-id="S001215">Ms. Stevens</cosponsor>, <cosponsor name-id="B001285">Ms. Brownley</cosponsor>, <cosponsor name-id="S000344">Mr. Sherman</cosponsor>, <cosponsor name-id="S001225">Mr. Sorensen</cosponsor>, <cosponsor name-id="T000468">Ms. Titus</cosponsor>, <cosponsor name-id="B001296">Mr. Boyle of Pennsylvania</cosponsor>, <cosponsor name-id="L000593">Mr. Levin</cosponsor>, <cosponsor name-id="T000482">Mrs. Trahan</cosponsor>, <cosponsor name-id="M001188">Ms. Meng</cosponsor>, <cosponsor name-id="M001225">Mr. Mullin</cosponsor>, <cosponsor name-id="C001068">Mr. Cohen</cosponsor>, <cosponsor name-id="C001119">Ms. Craig</cosponsor>, <cosponsor name-id="F000459">Mr. Fleischmann</cosponsor>, <cosponsor name-id="K000398">Mr. Kean of New Jersey</cosponsor>, <cosponsor name-id="S001214">Mr. Steube</cosponsor>, <cosponsor name-id="G000594">Mr. Tony Gonzales of Texas</cosponsor>, <cosponsor name-id="B001257">Mr. Bilirakis</cosponsor>, <cosponsor name-id="G000576">Mr. Grothman</cosponsor>, <cosponsor name-id="B001295">Mr. Bost</cosponsor>, <cosponsor name-id="M001222">Mr. Miller of Ohio</cosponsor>, <cosponsor name-id="R000609">Mr. Rutherford</cosponsor>, <cosponsor name-id="B001313">Ms. Brown</cosponsor>, <cosponsor name-id="T000463">Mr. Turner</cosponsor>, <cosponsor name-id="J000301">Mr. Johnson of South Dakota</cosponsor>, <cosponsor name-id="W000795">Mr. Wilson of South Carolina</cosponsor>, and <cosponsor name-id="K000392">Mr. Kustoff</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To authorize funding for a bilateral cooperative program with Israel for the development of health technologies.</official-title></form><legis-body id="H4A8DE74935814248814C6DF840E870F7" style="OLC"> 
<section id="H63F0B58A4462418A9010A1FB91F6428D" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>United States-Israel Health Technologies Cooperation Act</short-title></quote>.</text></section> <section id="H560BF7AAD6F4430BB64F0B6B4B4553D6"><enum>2.</enum><header>Bilateral cooperative agreement</header> <subsection id="H8FE6A4D98BF94D928C7C28A3B4E7EEC9"><enum>(a)</enum><header>Authorization of appropriations</header><text display-inline="yes-display-inline">There is authorized to be appropriated to the Secretary of Health and Human Services $4,000,000 for each of fiscal years 2024 through 2026 for a bilateral cooperative program with the Government of Israel for awarding grants for the development of health technologies, including such technologies described in subsection (b), subject to subsection (c), with an emphasis on collaboratively advancing the use of technology, personalized medicine, and data in relation to emerging infectious diseases.</text></subsection> 
<subsection id="HDEBDABEE7848407E949C0E629B61FB32"><enum>(b)</enum><header>Types of health technologies</header><text>The health technologies described in this subsection shall include technologies such as artificial intelligence, drugs and vaccinations, respiratory assist devices, diagnostic tests, and telemedicine.</text></subsection> <subsection id="HD55927BBAC434BAB82C978C2C808F7A9"><enum>(c)</enum><header>Restrictions on funding</header><text>The funding under subsection (a) is subject to a matching contribution from the Government of Israel.</text></subsection> 
<subsection id="HC8D2FD49D6564AAC864615F350421720"><enum>(d)</enum><header>Option for establishing new program</header><text>The amounts appropriated under subsection (a) may beâ€”</text> <paragraph id="H52E05EBB0B9A41D8A0ABB05D9D4633CE"><enum>(1)</enum><text>for a bilateral program with the Government of Israel that is in existence on the day before the date of enactment of this Act for the purposes described in such subsection; or</text></paragraph> 
<paragraph id="H0F2CBE70E9BE48EBB15701C1B08187E0"><enum>(2)</enum><text>for a bilateral program with the Government of Israel that is established after the date of enactment of this Act by the Secretary of Health and Human Services, in consultation with the Secretary of State, in accordance with the Agreement between the Government of the United States of America and the Government of the State of Israel on Cooperation in Science and Technology for Homeland Security Matters, done at Jerusalem May 29, 2008 (or a successor agreement), for the purposes described in subsection (a).</text></paragraph></subsection></section> </legis-body></bill>

